4Callow AD.Endothelial dysfunction in atherosclerosis [ J].Vascul Pharmacol,2002,38 (5):257-258.
5Golino P,Piscione F,Willerson JT,et al.Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients [ J ].N Engl J Med,1991,324(10):641-648.
6Lerman A,Holmes DR Jr,Bell MR,et al.Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans[ J].Circulation,1995,92 (9):2426-2431.
8Geisler T,Bhatt DL.The role of inflammation in atherothrombosis:current and future strategies of medical treatment [ J ].Med Sci Monit,2004,10 (12):RA308-316.
9Cybulsky MI,Iiyama K,Li H,et al.A major role for VCAM-1,but not ICAM-1,in early atherosclerosis [ J ].J Clin Invest,2001,107 (10):1255-1262.
10Boring L,Gosling J,Cleary M,et al.Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis[J].Nature,1998,394(6696):894-897.
